HUB Organoids predict patient response to treatment.
Our patented technology allows the development of patient-derived “mini-organs in a dish” from both healthy and diseased tissues to close the gap between the lab and the clinic.
HUB Organoids receives 2024 Frost & Sullivan Technology Innovation Leadership Award
Reduce drug attrition and predict patient response with our preclinical services and clinical trials in a dish
Decipher the complexity of the human disease with our custom model and assay development services
Bring HUB Organoid Technology and knowhow in-house
by bringing next-generation therapeutics to patients
|
Bring HUB Organoid Technology and knowhow in-house
|
Outsource your drug development program
|
